COVAX | WCMJX | COVAX / WCMJX | |
Total Expense Ratio | 1.21 | 1.10 | 110% |
Annual Report Gross Expense Ratio | 1.36 | 1.52 | 89% |
Fund Existence | 23 years | 6 years | - |
Gain YTD | -9.986 | -9.083 | 110% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 2000 | 1000 | 200% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 797M | 60.6M | 1,315% |
Annual Yield % from dividends | 1.74 | 0.00 | - |
Returns for 1 year | -24.61 | -17.23 | 143% |
Returns for 3 years | -21.29 | 7.10 | -300% |
Returns for 5 years | 16.59 | 37.13 | 45% |
Returns for 10 years | -27.58 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ALVAX | 21.74 | 0.21 | +0.98% |
American Beacon Large Cap Value A | |||
BCBDX | 12.01 | N/A | N/A |
BlackRock Global Dividend Inv C | |||
PABGX | 169.57 | N/A | N/A |
T. Rowe Price Blue Chip Growth Advisor | |||
DRMCX | 5.89 | N/A | N/A |
Virtus Silvant Mid-Cap Growth Inst | |||
LBISX | 20.01 | N/A | N/A |
BrandywineGLOBAL Div US Large Value IS |